Saturday Dec 7
Traders Recap- China New Borun Corp (NYSE:BORN), Star Scientific,...
CaddyStocks.com is keen to discover penny stocks with the potential to make short and long-term gains.
Mon Dec 02, 2013
Crain's Cleveland Business
Athersys plans to raise $20 million via stock sale
Athersys Inc. of Cleveland, a developer of adult stem cell therapies, plans to raise $20 million by issuing new shares, primarily to existing investors.
Wed Nov 27, 2013
Athersys Prices Registered Direct Offering of Common Stock and Warrants
Athersys, Inc. announced today that it has entered into definitive agreements to sell 10,000,000 shares of common stock and warrants to purchase up to 3,500,000 shares of common stock, in an offering with gross proceeds of $20.0 million.
Micro Cap Stocks Landing in the Bearish Zone - Andalay Solar...
StockRunway.com issues special report on - Andalay Solar Inc , AVEO Pharmaceuticals, Inc. , Athersys, Inc. , Genco Shipping & Trading Limited Andalay Solar Inc stock is at $0.0250, down -4.58 percent from its previous close of $0.0262.
Mon Nov 25, 2013
Athersys to Present at 25th Annual Piper Jaffray Healthcare Conference
Athersys, Inc. announced today that the Company will present at the 25th Annual Piper Jaffray Healthcare Conference taking place at The New York Palace on December 3rd and 4th , 2013 in New York City.
Thu Nov 21, 2013
Edison expands international biotechnology presence with launch of full coverage of Athersys
Edison's comprehensive report, Multipotent stem cells, was published on 25 October and examines the investment case for the development of rests on the outcome of two Phase II studies of its novel, off-the-shelf, stem cell therapy product, MultiStem.
Mon Nov 18, 2013
Athersys, Inc.: '2014'
Last week Athersys announced their quarterly earnings. As a shareholder, I find it important to listen to the quarterly conference calls because it gives shareholders insight as to the continued progress of the company.
Fri Nov 15, 2013
Two Ohio companies make Deloitte Fast 500
Ohio has two companies on the Deloitte Technology Fast 500 2013, which ranks the fastest-growing technology-based companies in North America.
Thu Nov 14, 2013
Athersys Management Discusses Q3 2013 Results - Earnings Call Transcript
Good afternoon. My name is Jamie, and I will be your conference operator today. At this time, I would like to welcome everyone to the Athersys Third Quarter Results Call.
Wed Nov 13, 2013
Athersys Recognized Among Fastest Growing Companies in North America...
" is committed to developing innovative therapies, like MultiStem , that have the potential to address substantial unmet medical needs, including stroke and other neurological conditions, heart and vascular disease, and inflammatory and immune conditions.
Athersys (ATHX) Scheduled to Post Earnings on Thursday
Athersys is set to release its Q3 earnings data after the market closes on Thursday, November 14th.